WallStSmart
QNCX

Quince Therapeutics, Inc.

NASDAQ: QNCX · HEALTHCARE · BIOTECHNOLOGY

$1.31
+6.50% today

Updated 2026-04-30

Market cap
$20.05M
P/E ratio
P/S ratio
EPS (TTM)
$-16.80
Dividend yield
52W range
$1 – $46
Volume
63.6M

Quince Therapeutics, Inc. (QNCX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
-53.9%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-44.2%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+1.8%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+5.3%
2026-03-03
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-03$-0.41-123.3%$0.10$0.10+5.3%
2025-11-13$-0.25-13.6%$1.71$1.68-1.8%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.18$-0.41-123.3%
2025-09-30$-0.22$-0.25-13.6%
2025-06-30$-0.26$-0.34-30.8%
2025-03-31$-0.23$-0.34-47.8%
2024-12-31$-0.10$-0.28-183.9%$168000.00
2024-09-30$-0.10$-0.13-27.2%
2024-06-30$-0.64
2024-03-31$-0.22$36000.00
2023-12-31$-0.28$-0.22+21.4%
2023-09-30$-0.15
2023-06-30$0.00$-0.14
2023-03-31$-0.31$-0.34-10.5%
2022-12-31$-0.29$-0.15+47.8%

Frequently asked questions

Has Quince Therapeutics, Inc. beaten earnings estimates?
Quince Therapeutics, Inc. has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports, with an average EPS surprise of -53.9% over the last 4 quarters.
How does QNCX stock react to earnings?
QNCX stock has moved an average of +1.8% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.